Proportion cured models applied to 23 cancer sites in Norway

International Journal of Cancer

Volumn 132, Issue 7, 2013, Pages 1700-1710

  Cvancarova, Milada ^a,b   Aagnes, Bjarte ^a   Lambert, Paul C ^c,d   Møller, Bjørn ^a   Bray, Freddie ^a,e,f  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF OSLO   (Norway)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

cancer sites; cure models; estimates; median survival; proportion cured; temporal trends; up to date

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; CONTROLLED STUDY; DEATH CERTIFICATE; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; NONHODGKIN LYMPHOMA; NORWAY; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; RECTUM CANCER; STOMACH CANCER; SURVIVAL TIME; TRACHEA CANCER;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MODELS, STATISTICAL; MORTALITY; NEOPLASMS; NORWAY; PROGNOSIS; REGISTRIES; SURVIVAL RATE;

EID: 84873096094     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27802     Document Type: Article

References (37)

1. Janssen-Heijnen M, Houterman S, Lemmens V, et al. Prognosis for long-term survivors of cancer. Ann Oncol 2007; 18: 1408-13.
2. de Angelis R, Capocaccia R, Hakulinen T, et al. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999; 18: 441-54.
3. Verdecchia A, de Angelis R, Capocaccia R., Estimation and projection of cancer prevalence from cancer registry data. Stat Med 2002; 21: 3511-26.
4. Lambert P., Modeling of the cure fraction in survival studies. Stata J 2007; 7: 1-25.
5. Francisci S, Capocaccia R, Grande E, et al. The cure of cancer: a European perspective. Eur J Cancer 2009; 45: 1067-79.
6. Lambert P, Dickman P, Osterlund P, et al. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the finish cancer registry. Int J Cancer 2007; 121: 2052-9.
7. Shah A, Stiller CA, Kenward MG, et al. Childhood leukeamia: long-term excess mortality and the proportion 'cured '. Br J Cancer 2008; 99: 219-23.
8. Larsen IK, Småstuen M, Johannesen T, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45:7: 1218-31.
9. Brenner H, Hakulinen T., Maximizing the benefit of model-based period analysis of cancer patient survival. Cancer Epidemiol Biomarkers Prev 2007; 16: 1675-81.
10. Ederer F, Axtell L, Cutler S., The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-21.
11. Dickman P, Coviello E, Hills M., Estimating and modeling relative survival. Stata J, in press.
12. Dickman P, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004: 23: 51-64.
13. Småstuen M, Aagnes B, Jonannesen TB, et al. Long-term cancer survival: patterns and trends in Norway 1965-2007. Oslo: Cancer Registry of Norway, 2008. http://kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/ CIN2007-del2.pdf.
14. Brenner H, Hakulinen T., Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. Am J Epidemiol 2002; 156: 566-77.
15. Brenner H, Gefeller O, Hakulinen T., Period analysis for "up-to-date" cancer survival, data theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40:3: 326-35.
16. Brenner H, Hakulinen T., Up-to-date long-term survival estimates of patients with cancer by period analysis. J Clin Oncol 2002; 20: 826-32.
17. Brenner H, Hakulinen T., Very-long-term survival rates of patients with cancer. J Clin Oncol 2002; 20: 4405-9.
18. Lambert P, Thomson J, Weston C, et al. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007; 8: 576-94.
19. Binbing Y, Tiwari R, Cronin K, et al. Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med 2004; 23: 1733-47.
20. Phillips N, Coldman A, McBride M., Estimating cancer prevalence using mixture models for cancer survival. Stat Med 2002; 21: 1257-70.
21. StataCorp. Stata Statistical Software. TX: StataCorp LP, Release 10; 2007.
22. Bejan-Angoulvant T, Bouvier A, Bossard N, et al. Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story? Eur J Epidemiol 2008; 23: 4:251-9.
23. Berrino F, de Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-83.
24. Black R, Bashir S., Interpretation of population-based cancer survival data. IARC Sci Publ 1998; 145: 13-7.
25. Cunningham D, Atkin W, Lenz H, et al. Colorectal cancer. Lancet 2010; 375: 1030-47.
26. O'Leary M, Krailo M, Anderson J, et al. Progress in childhood cancer: 50 years of research collaboration, a report from the children's oncology group. Semin Oncol 2008; 35:5: 484-93.
27. Kantarjian H, O'Brien S, Cortes J, et al. Therapeutic advances in leukaemia and myelodysplastic syndrome over past 40 years. Cancer 2008; 113:7: 1933-52.
28. Mueller C, Jeffries W., Cancer of the breast: its outcomes as measured by the rate of dying and causes of death. Ann Surg 1975; 182: 334-41.
29. McBride C, Brown B, Thompson J, et al. Can patients with breast cancer be cured of their disease? Cancer 1983; 51: 938-45.
30. Brenner H, Hakulinen T., Are patients diagnosed with breast cancer before age 50 years ever cured? J Clin Oncol 2004; 22:3: 432-8.
31. Oeffinger K, Nathan P, Kremer L., Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematol Oncol Clin North Am 2010; 24: 129-49.
32. Kiserud C, Loge J, Fosså A, et al. Mortality is persistently increased in Hodgkin's lymphoma survivors. Eur J Cancer 2010; 46:9: 1632-9.
33. Fosså S, Gilbert E, Dores G, et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 2007; 99:7: 533-44.
34. Micheli A, Ciapichini R, Oberaigner W, et al. EUROCARE Working Group: the advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45: 1017-27.
35. Lam K, Fong D, Tang O., Estimating the proportion of cured patients in a censored sample. Stat Med 2005; 24: 1865-79.
36. Sposto R., Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 2002; 21: 293-312.
37. Weston C, Douglas C, Craft A, et al. Establishing long-term survival and cure in young patients with Ewing's sarcoma. Br J Cancer 2004; 91: 225-32.